Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | +23 |
| Ticker | CPRX |
| Latest Price | 21.46 USD as of close on 03-Jul-2025 |
| 3 Month price range | 21.19 to 26.31 USD |
| Market Capitalisation | 2.62Bn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizures; Ruzurgi for the treatment of pediatric LEMS patients; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida. See More ... |
| Company URL | https://catalystpharma.com |
| See Darwins Full Analysis for Catalyst Pharmaceuticals Inc |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Catalyst Pharmaceuticals Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +1 |
| Sentiment | News and Candle Patterns. | +1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +8 |
| Flow | Institutional, Fund and Insider buying and selling. | -9 |
| Models | Forecast models. | +22 |
There are 2 live alerts for Catalyst Pharmaceuticals Inc. All the alerts are positive.
There are 6 peers of Catalyst Pharmaceuticals Inc.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Elevation Oncology Inc (ELEV) | Biotechnology | +27.5 | -5 |
| Revelation Biosciences Inc (REVB) | Biotechnology | -14.1 | -19 |
| Synaptogenix Inc (SNPX) | Biotechnology | +226.1 | +1 |
| TG Therapeutics Inc (TGTX) | Biotechnology | -0.9 | +34 |
| Vaxart Inc (VXRT) | Biotechnology | +5.7 | -16 |
| Windtree Therapeutics Inc (WINT) | Biotechnology | +38.7 | -21 |
To see complete information on Catalyst Pharmaceuticals Inc or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |